SEPTIN9 and cancer: Finally, the detection of methylated SEPT9 DNA was recommended as a noninvasive marker-based blood test for colorectal cancer screening in April 2016 [42], which suggests that gene methylation has a potential value as a noninvasive biomarker for cancer screening and diagnosis.